April 19, 2021
Applications are now open for QB3-Berkeley’s graduate student and postdoc science writing workshop, Science Writing for the Public: Share Your Research and Connect with Audiences. This three-part workshop will give participants training in writing science communications for a general audience.
April 13, 2021
A recent work published by the Schepartz laboratory at the UC Berkeley Department of Chemistry explores how a short helical protein can facilitate the delivery of proteins into cells, potentially offering scientists a streamlined method to efficiently deliver therapeutics to patients
April 12, 2021
Christopher J. Chang is one of this year’s 184 John Simon Guggenheim Memorial Foundation fellows. The prestigious awards recognize scholars with impressive achievements in fields ranging from the natural sciences to the creative arts.
April 12, 2021
Tailocins, which are extremely strong protein nanomachines made by bacteria, and their functions are an area of hot research due to their many possible applications. Scientists at the Berkeley Lab explored the genetic basis and physical mechanisms governing how tailocins attack specific strains, and looked at genetic similarities and differences between tailocin producers and their target strains.
April 06, 2021
Mike Holmes, PhD, is the Chief Scientific Officer at Ambys Medicines and is joining the QB3-Berkeley Professionals in Residence (PIR) program on April 16th and 23rd. He spoke with PhD student Diana Aguilar Gómez about his career from being a graduate student to industry and his pioneering work in genome editing techniques in gene therapy.
April 01, 2021
UC Berkeley researchers have invented a computer algorithm that uses deep learning to integrate gene and protein data about single cells.
April 01, 2021
CRISPR-Cas9 treatment of sickle cell disease has been approved for clinical trials by the U.S. Food and Drug Administration. Researchers will now test CRISPR-Cas9 on humans to directly correct the mutation in the beta-globin gene responsible for sickle cell disease.
March 25, 2021
Graduate student Riley Fricke sits down with Jeff Pelton, the manager of QB3-Berkeley’s 900 MHz NMR Facility, to discuss the facility and recent research that NMR spectroscopy has helped support.
Notifications